Quantcast
Channel: GenomeWeb - Cepheid
Browsing all 38 articles
Browse latest View live
↧

Danaher Q1 Revenues Up 4 Percent

View Article


FDA Clears Cepheid, Hologic CT/NG Assays for Extragenital Testing

View Article


Piper Jaffray Initiates Coverage of Danaher, Agilent

View Article

Life Sciences, Diagnostics Drive Danaher Q2 Revenues Up 4 Percent

View Article

UK Researchers Developing Blood-Based TB DNA Test, Eyeing Broader Screening

View Article


Molecular Testing for Flu Catching up, But Still Lagging Far Behind RIDTs

View Article

As M. Genitalium, Gonorrhea Molecular Testing Expands, Antibiotic Resistance...

View Article

SpeeDx Mycoplasma Genitalium Resistance Test on Cepheid System Receives CE-IVD

View Article


Chinese Biotech Startup Looks to Develop CRISPR-Based TB Diagnostic

View Article


Cepheid Xpert BCR-ABL Ultra Leukemia Monitoring Test Gets FDA Clearance

View Article

Danaher Q3 Revenues Up 4 Percent

View Article

Diagnostics Firms Rush to Develop Rapid Point-of-Care Tests for Novel...

View Article

POC Molecular Flu Tests Finding Resistance in Pediatrics Despite High Accuracy

View Article


Cepheid, Sherlock Biosciences Partner on SARS-CoV-2 Diagnostic Test

View Article

Testing, Testing For It

View Article


Cepheid Coronavirus Assay First Point-of-Care Test to Get FDA Emergency Use...

View Article

Decentralized Molecular Testing a Potential 'Game Changer' For COVID-19 Outbreak

View Article


CMS Increases Payment Rates for High-Throughput SARS-CoV-2 Tests

View Article

Missed Ones

View Article

Danaher Q1 Revenues Up 3 Percent; Joyce Retiring as CEO

View Article
Browsing all 38 articles
Browse latest View live